Anbex Inc.
St. George, UT
- UEI
- Y7EJCKML9FW7
- CAGE
- 1XZ60
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1812 W Sunset Blvd 1a 618, St. George, UT 84770, USA
- Website
- anbex.com
- Founded
- 1982
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $30,690 |
| FY2025 | $476,008 |
| FY2024 | $419,730 |
| FY2023 | $421,086 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Logistics Agency | $30,690 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Iosat 130 MG tablet 14S | Medical Supply Chain (DLA) | $743 | |
| Iosat 130 MG tablet 14S | Medical Supply Chain (DLA) | $413 | |
| Iosat 130 MG tablet 14S | Medical Supply Chain (DLA) | $2,475 | |
| Iosat 130 MG tablet 14S | Medical Supply Chain (DLA) | $22,853 | |
| Iosat 130 MG tablet 14S | Medical Supply Chain (DLA) | $4,950 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Heyltex Corporation | — | 325414 Biological Product (except Diagnostic) Manufacturing |
| BTG International Inc. | Gladwyne, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Fagron Sterile Services | Wichita, KS | 325412 Pharmaceutical Preparation Manufacturing |
| Potable Aqua | Jackson, WI | 325412 Pharmaceutical Preparation Manufacturing |
| Purdue Pharma LIMITED Partnership | Stamford, CT | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Anbex Inc., a for-profit Subchapter S corporation based in St. George, Utah, manufactures and supplies potassium iodide tablets and related pharmaceutical products to the federal government as a prime contractor under full-and-open competition across all recent awards.
Anbex operates almost exclusively as a single-customer supplier. The Defense Logistics Agency Troop Support Medical accounts for 318 of 357 total awards (89% of the award count) and $3.52 billion of the $3.54 billion combined potential value (99.4% of dollars). This concentration reflects Anbex's dominant role as the primary potassium iodide tablet supplier for the federal medical supply chain. The vendor holds a $3.5 billion indefinite delivery contract with DLA Troop Support Medical running through September 2030, which serves as the parent vehicle for the overwhelming majority of work. Recent representative delivery orders include a $4,950 order for IOSAT 130 mg tablets awarded January 23, 2026; a $335,028 order for other medical supplies awarded September 12, 2025; and a $192,782 order for other medical products awarded September 22, 2022, all under the same DLA IDC. The second-largest customer, the Department of Health and Human Services Office of the Assistant Secretary for Administration, accounts for only 19 awards valued at $9.3 million combined. Anbex has also worked with the Nuclear Regulatory Commission, the Department of Veterans Affairs, the Department of State, and the Centers for Disease Control and Prevention on smaller awards.
Work is performed at Anbex's facilities in St. George, Utah and Williamsburg, Virginia. The vendor's NAICS footprint centers on medicinal and botanical manufacturing (190 awards) and pharmaceutical preparation manufacturing (143 awards), with 346 of 357 awards classified under Drugs and Biologicals PSC. Anbex has not competed under set-aside categories in the recent award record; all procurement has been full-and-open.
Activity has declined year over year from a peak of 39 awards in 2022 to 16 awards in 2024 and 9 awards in 2025, suggesting a shift in DLA ordering patterns toward fewer, larger delivery orders rather than smaller ones. The combined value of awards with ultimate completion dates in the next twenty-four months totals $335 thousand, indicating minimal near-term recompete exposure. Combined dollars obligated across all 357 awards stands at $22.3 million against $3.54 billion in combined potential value, reflecting the firm-fixed-price delivery-order structure under which DLA issues orders but does not obligate the full ceiling value upfront. Anbex has maintained federal contractor registration since April 2002.
Quick answers
Is Anbex Inc. registered in SAM.gov?
Yes. Anbex Inc.'s SAM.gov registration is active through May 28, 2027.
How much has Anbex Inc. received in federal contracts?
Federal contracts obligated $476,008 to Anbex Inc. in fiscal year 2025 and $1,347,514 in fiscal years 2023 through 2027.
How does Anbex Inc. rank among federal contractors?
Anbex Inc. ranked #53 in NAICS 325414 in FY2025.
What is Anbex Inc.'s most recent federal award?
Anbex Inc.'s most recent federal contract award is Iosat 130 MG tablet 14S (SPE2D326F300F), from Medical Supply Chain (DLA), on July 27, 2026.
On GovTribe
See Anbex Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors